Literature DB >> 12100335

Plasma endothelin, nitric oxide and atrial natriuretic peptide levels in humans after abdominal angiography.

R Murakami1, M Machida, H Tajima, H Hayashi, N Uchiyama, T Kumazaki.   

Abstract

PURPOSE: To clarify the effect of the contrast medium iopamidol on endothelial function and response of vasoactive peptide, as measured by changes in the levels of plasma endothelin, nitric oxide and atrial natriuretic peptide.
MATERIAL AND METHODS: Thirteen patients received iopamidol 300 mg I/ml intra-arterially during routine abdominal angiography. The mean volume of contrast medium administered was 208.1+/-32.5 ml. Endothelin, nitric oxide and atrial natriuretic peptide were measured before and after angiography.
RESULTS: Endothelin levels increased significantly (from 1.45+/-0.12 pg/ml to 1.90+/-0.10 pg/ml) after exposure to contrast medium. Nitric oxide levels decreased significantly (from 34.56+/-2.23 micromol/ to 25.43+/-1.83 micromol/l). Atrial natriuretic peptide levels increased significantly (from 11.43+/-1.68 pg/ml to 21.28+/-2.89 pg/ml).
CONCLUSION: Exposure to contrast medium in humans is associated with an increase in plasma endothelin levels and a decrease in nitric oxide levels, and atrial natriuretic peptide levels also increase following CM injection.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12100335     DOI: 10.1080/j.1600-0455.2002.430319.x

Source DB:  PubMed          Journal:  Acta Radiol        ISSN: 0284-1851            Impact factor:   1.990


  2 in total

1.  Heme oxygenase-1 counteracts contrast media-induced endothelial cell dysfunction.

Authors:  Chao-Fu Chang; Xiao-Ming Liu; Kelly J Peyton; William Durante
Journal:  Biochem Pharmacol       Date:  2013-11-15       Impact factor: 5.858

2.  The protective effect of single dose tadalafil in contrast-induced nephropathy: an experimental study.

Authors:  Kerem Özbek; Köksal Ceyhan; Fatih Koç; Erkan Söğüt; Fatih Altunkaş; Metin Karayakalı; Ataç Çelik; Hasan Kadı; R Doğan Köseoğlu; Orhan Önalan
Journal:  Anatol J Cardiol       Date:  2014-04-16       Impact factor: 1.596

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.